Breakthrough study reveals traditional remedy outperforms synthetic drugs in disintegrating harmful brain proteins.
A New Approach to Alzheimer’s Treatment
A groundbreaking study led by Professor Anirban Bhunia and his team at the Bose Institute, Kolkata, has introduced a dual-strategy treatment that offers significant hope for Alzheimer’s and related neurodegenerative diseases.
- The team combined synthetically designed peptides with a repurposed Ayurvedic formulation, Lasunadya Ghrita (LG), to tackle harmful brain protein aggregates.
- This multipronged approach targets amyloid beta (Aβ) 40/42, a protein strongly associated with Alzheimer’s pathology.
Why Amyloid Proteins Matter
In Alzheimer’s disease, amyloid beta proteins misfold and accumulate into plaques, disrupting brain function.
- These aggregates damage neurons, leading to memory loss, cognitive decline, and behavioral changes.
- Preventing or reversing amyloid aggregation has been a major focus of Alzheimer’s research.
Chemically Designed Peptides: Effective But Limited
The team synthesized small peptide molecules to target and inhibit amyloid formation.
- These peptides proved to be non-toxic, serum-stable, and effective in halting aggregation.
- They also showed capacity to disaggregate existing amyloid clumps into smaller, non-toxic units.
- Published in Biochemistry (ACS), this finding reinforces the potential of synthetic molecules in managing AD.
The Ayurvedic Breakthrough: Lasunadya Ghrita (LG)
In a remarkable twist, the researchers also tested LG, an ancient Ayurvedic medicinal formulation traditionally used for mental health and depression.
- Using water-based extracts (LGWE), the team observed that the compound:
- Disrupted amyloid fibrillation during its elongation phase,
- Inhibited oligomer formation at early stages,
- And most impressively, broke down existing amyloid aggregates more effectively than the synthetic peptides.
- The findings, published in Biophysical Chemistry (Elsevier), suggest natural compounds in LG may hold superior therapeutic potential.
Ayurveda and Modern Science: A Powerful Collaboration
This study exemplifies a successful collaboration between modern biomedical science and traditional medicine:
- Involvement of Professor Dr. Sanjeev Rastogi, an Ayurvedic expert from Lucknow University, strengthened the interdisciplinary integrity of the work.
- Researchers from IIT-Guwahati and Saha Institute of Nuclear Physics further validated the findings with advanced biochemical analysis.
The Road Ahead: From Lab to Lives
While still in the experimental phase, this dual-approach therapy could revolutionize treatment for neurodegenerative diseases like Alzheimer’s and Dementia.
- The evidence supports further clinical exploration of Ayurvedic formulations alongside synthetic drugs.
- If successful in clinical trials, this could lead to accessible, cost-effective, and safer treatments for millions affected worldwide.
A new study reveals that an Ayurvedic remedy, Lasunadya Ghrita, is more effective than synthetic peptides in breaking down Alzheimer’s-related amyloid proteins. Combining ancient wisdom with modern science, this dual-approach could lead to safer, natural treatment options for neurodegenerative diseases.
